Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by JDavenporton Aug 31, 2022 2:49pm
90 Views
Post# 34933232

RE:RE:Gene Therapies

RE:RE:Gene Therapies
Lol, yup, it's just capitalism, pof, survival of the fittest. 
 
That's swell if you're the survivor, pof. I don't think that enzyme replacement therapies will be a big deal, maybe not extinct but at least on the threatened list.
 
Why do you suppose that ArmaGen was able to enter a deal for Hunter syndrome with Shire for $15 million up front and $225 million in milestones back in 2014? You know, when Bioasis was making big talk and I was screaming for clinical programs to move this forward?
 
Now, $3 million up front and milestones of $138 million for four LSDs. Why do you suppose the value of LSDs dropped so drastically?

I'll stick with my thoughts about this.
 
jd
<< Previous
Bullboard Posts
Next >>